Answers - Real Estate

Even in a softening market, real estate can be a lucrative venture for investment. In order to see a real profit from the efforts that go in,

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

a sound and solid strategy is needed. Despite the fact that every smart investor should have a strategy, the strategy developed is a highly pe

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

rsonal plan.

The goals are specific to the individual investor along with the time and resources they may have at their disposal. Additionall

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

y, it is things like research and the overall dedication that really make each strategy so different from the next, although the ultimate goal

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

(to make money) may be the same.

Having a strategy helps investor's face three of the most common problems they immediately face:

1:Mos

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

t "gurus" promote ideas/strategies that worked when the market was hot. Investors need to investigate if the "strategy" the pros discu

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

ss will actually work in the current market. Not only that, what they say may not fit in with what an investor (especially a new investor) is

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

ble to accomplish.

Factors such as time and skills need to be considered. One of the smartest things any investor can do to increase their pr

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

ofits is educate themselves on every necessary aspect of the process; be the expert. Henceforth, a shrewd investor will figure out how to make

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

the most money from what they've learned, whether it be flipping, assignments, consulting, etc.

However, what works for one investor may not

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

work for another. Before trying anything, be 100% certain that the plan will work in the current market.

2: Most investors lack a clear

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

ly defined objective. How can anyone work toward a goal if there isn't one? This is true with most things in life. People need to kn

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

ow what they're working toward or they wander aimlessly.

Even embarking on a road trip to a new destination requires a map; there must be a fi

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

nal destination as well as detailed instructions on how to get there. Without a goal, investors will only waste their time and efforts spinnin

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

their wheels.

3: Investors seem to be looking for the elusive "magic bullet" solution. The short answer is that there is no "m

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

agic bullet" or get-rich-quick answer. There is no quick-fix for any situation. Especially in an investment situation, sustained profits will

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

only occur as the pay off for the time put in from the beginning.

Plus, a strategy that works in one market may not be appropriate for anothe

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

r. Necessary research is required in order to know what will work in a specific market.

Some strategies aren't as risky as others; they also

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

will not yield as high a profit. It's important to know from the beginning what the desired end is. Riskier strategies may simply be too time

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

-consuming and complicated to embrace early on in the game. Each investor needs to move at their own speed. No one will be able to predict it

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.answers.org.ua/article/131680/answers-Real-Estate-Investing--How-To-Pick-The-Best-Strategy.html">Real Estate Investing - How To Pick The Best Strategy</a>

BB link (for phorums):
[url=http://www.answers.org.ua/article/131680/answers-Real-Estate-Investing--How-To-Pick-The-Best-Strategy.html]Real Estate Investing - How To Pick The Best Strategy[/url]

Costs of over regulation and over disclosure end up hurting the very consumer that the regulatory bodies are trying to protect. Over disclosure and over regulation is in itself the worst evil of civilization, as it stifles free enterprise, innovation and free markets.

There's a lot more to getting the best balance transfer credit card deals than looking at the rate offered. The length of the introductory rate, the rate offered during the introduction, the standard rate imposed after the introduction, the annual fee, the credit level required to be accepted and many other things written in the fine print all must be considered to determine what are really the best balance transfer credit card deals.

Car loans are an easy way to cut short your wait to owning the car that you desire. You have stared long enough at the sparkling new car model at the showroom. Now is the time to get behind the steering wheel and make your dream of owning a car a reality

Tags

Links

Answers - Real Estate Investing - How To Pick The Best Strategy

Related Articles: